# Current Context

Latest checkpoint: `110_coverage-expansion-wave-1.md`
Progress: `110%`

## Compressed State

Expanded the normalization catalog and conversion registry to include LDL cholesterol, HDL cholesterol, triglycerides, and creatinine, then verified the new coverage through a dedicated slice-specific checker script and CLI run.

## Locked Decisions

- New coverage slices should prefer dedicated on-the-spot verification scripts over expanding a generic static test file
- Coverage expansion remains deterministic and specimen-aware
- Post-alpha progress now continues past 100% in 10% slices

## Immediate Next Steps

- Add broader alias and edge-case coverage for common vendor naming patterns
- Expand the fixture set with the next biomarker group
- Decide whether the next wave should include FHIR-specific validation for added markers

## Resume From

Start from project_memory/current_context.md and project_memory/roadmap.md, then move into the 120% alias and edge-case expansion wave.
